These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 36621732)

  • 21. Passive immunization targeting the N-terminal region of phosphorylated tau (residues 68-71) improves spatial memory in okadaic acid induced tauopathy model rats.
    Subramanian S; Savanur G; Madhavadas S
    Biochem Biophys Res Commun; 2017 Jan; 483(1):585-589. PubMed ID: 27998769
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Photo-Excited Dyes: Emerging Technique Against Tau Protein Aggregation.
    Chinnathambi S; Dubey T
    Methods Mol Biol; 2024; 2754():105-116. PubMed ID: 38512663
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peptides, Peptidomimetics, and Carbohydrate-Peptide Conjugates as Amyloidogenic Aggregation Inhibitors for Alzheimer's Disease.
    Ryan P; Patel B; Makwana V; Jadhav HR; Kiefel M; Davey A; Reekie TA; Rudrawar S; Kassiou M
    ACS Chem Neurosci; 2018 Jul; 9(7):1530-1551. PubMed ID: 29782794
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of ortho catechol-containing isoflavone as a privileged scaffold that directly prevents the aggregation of both amyloid β plaques and tau-mediated neurofibrillary tangles and its in vivo evaluation.
    Son SH; Do JM; Yoo JN; Lee HW; Kim NK; Yoo HS; Gee MS; Kim JH; Seong JH; Inn KS; Seo MD; Lee JK; Kim NJ
    Bioorg Chem; 2021 Aug; 113():105022. PubMed ID: 34098397
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SLM, a novel carbazole-based fluorophore attenuates okadaic acid-induced tau hyperphosphorylation via down-regulating GSK-3β activity in SH-SY5Y cells.
    Wu X; Kosaraju J; Tam KY
    Eur J Pharm Sci; 2017 Dec; 110():101-108. PubMed ID: 28359686
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Structure Biology of Tau and Clue for Aggregation Inhibitor Design.
    Wang D; Huang X; Yan L; Zhou L; Yan C; Wu J; Su Z; Huang Y
    Protein J; 2021 Oct; 40(5):656-668. PubMed ID: 34401998
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fulvic acid inhibits aggregation and promotes disassembly of tau fibrils associated with Alzheimer's disease.
    Cornejo A; Jiménez JM; Caballero L; Melo F; Maccioni RB
    J Alzheimers Dis; 2011; 27(1):143-53. PubMed ID: 21785188
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A local insult of okadaic acid in wild-type mice induces tau phosphorylation and protein aggregation in anatomically distinct brain regions.
    Baker S; Götz J
    Acta Neuropathol Commun; 2016 Mar; 4():32. PubMed ID: 27037086
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro 0N4R tau fibrils contain a monomorphic β-sheet core enclosed by dynamically heterogeneous fuzzy coat segments.
    Dregni AJ; Mandala VS; Wu H; Elkins MR; Wang HK; Hung I; DeGrado WF; Hong M
    Proc Natl Acad Sci U S A; 2019 Aug; 116(33):16357-16366. PubMed ID: 31358628
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sunset yellow degradation product, as an efficient water-soluble inducer, accelerates 1N4R Tau amyloid oligomerization: In vitro preliminary evidence against the food colorant safety in terms of "Triggered Amyloid Aggregation".
    Ojaghi S; Mohammadi S; Amani M; Ghobadi S; Bijari N; Esmaeili S; Khodarahmi R
    Bioorg Chem; 2020 Oct; 103():104123. PubMed ID: 32781343
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anthraquinones inhibit tau aggregation and dissolve Alzheimer's paired helical filaments in vitro and in cells.
    Pickhardt M; Gazova Z; von Bergen M; Khlistunova I; Wang Y; Hascher A; Mandelkow EM; Biernat J; Mandelkow E
    J Biol Chem; 2005 Feb; 280(5):3628-35. PubMed ID: 15525637
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Charge neutralization of lysine via carbamylation reveals hidden aggregation hot-spots in tau protein flanking regions.
    Gadhavi J; Shah S; Sinha T; Jain A; Gupta S
    FEBS J; 2022 May; 289(9):2562-2577. PubMed ID: 34796642
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structurally Distinct Polymorphs of Tau Aggregates Revealed by Nanoscale Infrared Spectroscopy.
    Banerjee S; Ghosh A
    J Phys Chem Lett; 2021 Nov; 12(45):11035-11041. PubMed ID: 34747175
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Baicalein inhibits heparin-induced Tau aggregation by initializing non-toxic Tau oligomer formation.
    Sonawane SK; Uversky VN; Chinnathambi S
    Cell Commun Signal; 2021 Feb; 19(1):16. PubMed ID: 33579328
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circular Dichroism Spectroscopy Identifies the β-Adrenoceptor Agonist Salbutamol As a Direct Inhibitor of Tau Filament Formation
    Townsend DJ; Mala B; Hughes E; Hussain R; Siligardi G; Fullwood NJ; Middleton DA
    ACS Chem Neurosci; 2020 Jul; 11(14):2104-2116. PubMed ID: 32520518
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection and Quantification Methods for Fibrillar Products of In Vitro Tau Aggregation Assays.
    Nanavaty N; Lin L; Hinckley SH; Kuret J
    Methods Mol Biol; 2017; 1523():101-111. PubMed ID: 27975246
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of Melatonin on Tau aggregation and Tau-mediated cell surface morphology.
    Das R; Balmik AA; Chinnathambi S
    Int J Biol Macromol; 2020 Jun; 152():30-39. PubMed ID: 32044365
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Granular tau oligomers as intermediates of tau filaments.
    Maeda S; Sahara N; Saito Y; Murayama M; Yoshiike Y; Kim H; Miyasaka T; Murayama S; Ikai A; Takashima A
    Biochemistry; 2007 Mar; 46(12):3856-61. PubMed ID: 17338548
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tau-Centric Multitarget Approach for Alzheimer's Disease: Development of First-in-Class Dual Glycogen Synthase Kinase 3β and Tau-Aggregation Inhibitors.
    Gandini A; Bartolini M; Tedesco D; Martinez-Gonzalez L; Roca C; Campillo NE; Zaldivar-Diez J; Perez C; Zuccheri G; Miti A; Feoli A; Castellano S; Petralla S; Monti B; Rossi M; Moda F; Legname G; Martinez A; Bolognesi ML
    J Med Chem; 2018 Sep; 61(17):7640-7656. PubMed ID: 30078314
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selection and Characterization of Tau Binding ᴅ-Enantiomeric Peptides with Potential for Therapy of Alzheimer Disease.
    Dammers C; Yolcu D; Kukuk L; Willbold D; Pickhardt M; Mandelkow E; Horn AH; Sticht H; Malhis MN; Will N; Schuster J; Funke SA
    PLoS One; 2016; 11(12):e0167432. PubMed ID: 28006031
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.